MicroRNA-196a is regulated by ER and is a prognostic biomarker in ER+ breast cancer

被引：0
|
作者：
Michael J. G. Milevskiy
Udai Gujral
Carolina Del Lama Marques
Andrew Stone
Korinne Northwood
Lez J. Burke
Julia M. W. Gee
Kenneth Nephew
Susan Clark
Melissa A. Brown
机构：
[1] University of Queensland,School of Chemistry and Molecular Biosciences
[2] Garvan Institute of Medical Research,Division of Genomics and Epigenetics, Epigenetics Research Laboratory
[3] The University of Queensland,UQ Centre for Clinical Research
[4] Cardiff University,School of Pharmacy and Pharmaceutical Sciences
[5] Indiana University,School of Medicine
[6] The Walter and Eliza Hall Institute of Medical Research,ACRF Stem Cells and Cancer
来源：
British Journal of Cancer | 2019年 / 120卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：621 / 632
页数：11
相关论文
共 50 条
  • [21] TPD52 is a prognostic biomarker and potential therapeutic target for ER+/PR+/HER2+ breast cancer
    Cheng, Xiaolin
    Li, Zhengdong
    Jia, Xiaoqing
    Fan, Zhiyuan
    He, Qizhi
    Zhuang, Zhigang
    CHINESE CLINICAL ONCOLOGY, 2024, 13 (03)
  • [22] Treatment of ER+/HER2+breast cancer
    Johnston, Stephen
    CANCER RESEARCH, 2023, 83 (05)
  • [23] Second Oral SERD Shines in ER+ Breast Cancer
    Pob, Alissa
    CANCER DISCOVERY, 2023, 13 (03) : 522
  • [24] TILs in ER+/HER2-breast cancer
    Criscitiello, C.
    Vingiani, A.
    Maisonneuve, P.
    Viale, G.
    Viale, G.
    Curigliano, G.
    ANNALS OF ONCOLOGY, 2019, 30 : 3 - 3
  • [25] Next-Generation ERα Inhibitors for Endocrine-Resistant ER+ Breast Cancer
    Fanning, Sean W.
    Greene, Geoffrey L.
    ENDOCRINOLOGY, 2019, 160 (04) : 759 - 769
  • [26] MicroRNA-196a as a Potential Diagnostic Biomarker for Esophageal Squamous Cell Carcinoma
    Fendereski, Mona
    Zia, Mohammad Farid
    Shafiee, Mohammad
    Safari, Forousan
    Saneie, Mohammad Hosien
    Tavassoli, Manoochehr
    CANCER INVESTIGATION, 2017, 35 (02) : 78 - 84
  • [27] Circulating microRNA-196a as a candidate diagnostic biomarker for chronic hepatitis C
    Liu, Bo
    Xiang, Ying
    Zhang, Heng-Shu
    MOLECULAR MEDICINE REPORTS, 2015, 12 (01) : 105 - 110
  • [28] Differential bone morphology and hypoxia activity in skeletal metastases of ER+ and ER- breast cancer
    Das, Anindita
    Barry, Megan M.
    Ernst, Cheyenne A.
    Dahiya, Renuka
    Kim, Minhyung
    Rosario, Spencer R.
    Lo, Hin Ching
    Yu, Cuijuan
    Dai, Tao
    Gugala, Zbigniew
    Zhang, Jianmin
    Dasgupta, Subhamoy
    Wang, Hai
    COMMUNICATIONS BIOLOGY, 2024, 7 (01)
  • [29] Testosterone, estradiol and risk factors for prediction of ER+ and ER- breast cancer in older women
    Cummings, SR
    Lee, J
    Lui, L
    Cauley, JA
    OSTEOPOROSIS INTERNATIONAL, 2002, 13 : S13 - S13
  • [30] ERα-Mediated Nuclear Sequestration of RSK2 Is Required for ER+ Breast Cancer Tumorigenesis
    Ludwik, Katarzyna A.
    McDonald, Oliver G.
    Brenin, David R.
    Lannigan, Deborah A.
    CANCER RESEARCH, 2018, 78 (08) : 2014 - 2025
12345